These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9462638)

  • 61. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours.
    Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S
    Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
    Kubo Y; Okuda K; Shimokawa Y; Arishima T; Nagata E
    Gastroenterology; 1977 Jun; 72(6):1213-6. PubMed ID: 67061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Increase in peripheral and liver infiltrating regulatory T cells favors development of primary hepatocellular carcinoma].
    Wang SY; Fu JL; Lv JY; Chen LM; Lv S; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):668-70. PubMed ID: 21651872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.
    Oka M; Hazama S; Suzuki M; Ogura Y; Kobayashi N; Suzuki T
    Hepatogastroenterology; 1995; 42(5):561-6. PubMed ID: 8751216
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The interstitial response and postoperation recurrent mechanism in liver cancer].
    Dai Y; Chen H; Wang N
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):666-9, 709. PubMed ID: 8697086
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical significance of immune cell infiltration within gallbladder cancer.
    Nakakubo Y; Miyamoto M; Cho Y; Hida Y; Oshikiri T; Suzuoki M; Hiraoka K; Itoh T; Kondo S; Katoh H
    Br J Cancer; 2003 Nov; 89(9):1736-42. PubMed ID: 14583778
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-mediated immune responses to alpha-fetoprotein and other antigens in hepatocellular carcinoma.
    Behboudi S; Boswell S; Williams R
    Liver Int; 2010 Apr; 30(4):521-6. PubMed ID: 20040052
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical features of anti-HCV antibody positive hepatocellular carcinoma].
    Hayashi S; Tanaka S; Wakashima M; Saeki S; Tanaka T; Shibayama T; Otake H; Hattori N
    Nihon Rinsho; 1991 Feb; 49(2):432-8. PubMed ID: 1849205
    [No Abstract]   [Full Text] [Related]  

  • 69. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma.
    Ikeguchi M; Oi K; Hirooka Y; Kaibara N
    Eur J Surg Oncol; 2004 Feb; 30(1):53-7. PubMed ID: 14736523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
    Kang HJ; Oh JH; Chun SM; Kim D; Ryu YM; Hwang HS; Kim SY; An J; Cho EJ; Lee H; Shim JH; Sung CO; Yu E
    J Hepatol; 2019 Jul; 71(1):91-103. PubMed ID: 30930222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Small hepatocellular carcinoma. DNA content and biological characteristics.
    Cong WM; Wu MC
    Chin Med J (Engl); 1989 Oct; 102(10):783-5. PubMed ID: 2560954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of biliary antigen and its clinical significance in hepatocellular carcinoma.
    Yoon DS; Jeong J; Park YN; Kim KS; Kwon SW; Chi HS; Park C; Kim BR
    Yonsei Med J; 1999 Oct; 40(5):472-7. PubMed ID: 10565259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A clinico-pathological study involving a consecutive series of 75 primary liver carcinomas with resection].
    Haratake J; Horie A; Takeda S; Hisatomi K; Tokudome S
    Gan No Rinsho; 1988 May; 34(6):759-63. PubMed ID: 2837593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.
    Giuşcă SE; Zugun FE; Târcoveanu E; Carasevici E; Amălinei C; Căruntu ID
    Rom J Morphol Embryol; 2010; 51(1):73-9. PubMed ID: 20191123
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic effect of stromal lymphocyte infiltration in thymic carcinoma.
    Shim HS; Byun CS; Bae MK; Lee CY; Park IK; Kim DJ; Chung KY; Lee JG
    Lung Cancer; 2011 Nov; 74(2):338-43. PubMed ID: 21492951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Immunocellular response to fetal antigens in patients with hepatoma (author's transl)].
    Uribarrena R; Pérez Miranda M; Pons F; Amézaga A; Cabarcos A
    Med Clin (Barc); 1979 Nov; 73(8):327-33. PubMed ID: 93178
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decrease in size of non-treated lesions after cryoablation for hepatocellular carcinoma.
    Zhou L; Wang CP; Lu YY; Bai WL; Qu JH; Lou M; Zeng Z; Wu Y; Chen Y; Wang H; Chang XJ; Yang YP
    Hepatogastroenterology; 2012; 59(113):252-4. PubMed ID: 22260835
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.
    Valente G; De Stefani A; Jemma C; Giovarelli M; Geuna M; Cortesina G; Forni G; Palestro G
    Mod Pathol; 1990 Nov; 3(6):702-8. PubMed ID: 2263594
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
    Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
    Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Prognostic value of B lymphocyte infiltration in breast cancer].
    Yu H; Yang J; Jiao S; Wang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):750-5. PubMed ID: 23689000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.